Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Overview
US medical device maker's Q1 revenue was flat yr/yr at $1.8 mln
Company completed up to $30.1 mln financing to support commercial expansion
Outlook
Company reaffirms 2026 revenue guidance of $8 mln, excluding second-generation LungFit PH system
Beyond Air maintains 2027 revenue guidance of $16-$18 mln, including anticipated LungFit PH revenue
Company expects FDA approval for second-generation LungFit PH system in 2H 2026
Result Drivers
COMMERCIAL PREPARATIONS - Co said it focused on building commercial infrastructure, customer relationships and sales pipeline ahead of anticipated LungFit PH system launch
DISTRIBUTION EXPANSION - Co expanded global distribution network for LungFit PH to over 45 countries and signed a new U.S. group purchasing agreement
LOWER R&D SPENDING - Co reported reduced research and development expenses compared to prior year
Company press release: ID:nGNX6HNMcy
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Loss Per Share |
| $11 |
|
Q1 Net Loss | Miss | $8.15 mln | $7.35 mln (2 Analysts) |
Q1 Operating loss | Miss | -$6.61 mln | -$6.39 mln (2 Analysts) |
Q1 Gross Profit |
| $225,000 |
|
Q1 Operating Expenses |
| $6.84 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Beyond Air Inc is $280.00, about 4,528.1% above its August 12 closing price of $6.05
Reuters Recommended Reads
Aug 12 - Liquidia Q2 revenue jumps on YUTREPIA sales
Aug 12 - Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Aug 10 - Teledyne to acquire Varex Imaging in $1.1 billion deal
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Beyond Air
See all newsBrief: Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments
Beyond Air Inc reports results for the quarter ended June 30 - Earnings Summary
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Beyond Air Inc expected to post a loss of $10.80 a share - Earnings Preview
NASDAQ RESUMED AT 04:00 AM